クレアチニンアッセイキット市場 - 成長、傾向、予測（2020年～2025年）
Creatinine Assay Kits Market - Growth, Trends, and Forecast (2020 - 2025)
|クレアチニンアッセイキット市場 - 成長、傾向、予測（2020年～2025年）|
発行: Mordor Intelligence LLP
ページ情報: 英文 120 Pages
The Creatinine Assay Kits Market is expected to register a CAGR of 5.3% during the forecast period. Creatinine assay kits are used to measure creatinine levels in serum/plasma, urine and other biological samples. Creatinine is a waste product produced by muscles from the breakdown of creatine compound and removed from the body by the kidneys, which filter from the blood and release it into the urine. Creatinine assay is used to analyze the protein metabolism in the body and the levels of creatinine can be affected by changes in muscle mass, pregnancy, cancer, etc. Creatinine levels in the blood will increase and will deflect in the blood test if the kidney is not in the good condition. Creatinine test is performed by using specific creatinine assay kit and can be performed for different conditions like hypertension, diabetes and cancers. According to International Society of Nephrology, every year approximately 13.3 million cases of acute kidney injury (AKI) globally, particularly high in emerging countries, where annual incidence is estimated to be 11.3 million. Increasing incidence of renal disorders and other chronic disorders, technological advancements in biomedical research pertaining to kidney disorders and increasing research and development initiatives are the key driving factors in creatinine assay kits market.
Jaffe's Kinetic Test Kits Segment is Expected to Hold a Major Market Share in the Creatinine Assay Kits Market
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global creatinine assay kits market due to increasing incidence of renal disorders and other chronic disorders impacting renal function and technological advancements in biomedical research pertaining to kidney disorders in this region. According to the Centers for Disease Control and Prevention (CDC), approximately 30 million people or 15% of United States adults are estimated to have chronic kidney disease (CKD). chronic kidney disease (CKD) is estimated to be more common in women (16%) than in men (13%). Furthermore, favourable reimbursement policies and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.
The Creatinine Assay Kits Market is highly fragmented competitive and consists of several major players. In terms of market share, majority of the players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation, Cell Biolabs, Inc, Genway Biotech, Randox Laboratories Ltd, ACON Laboratories, Nova Biomedical and Sysmex India Pvt. Ltd.